ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. (2020)
Attributed to:
An integrated genetic and proteomic approach to understanding cardiovascular disease aetiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1098/rsos.200958
PubMed Identifier: 33391794
Publication URI: http://europepmc.org/abstract/MED/33391794
Type: Journal Article/Review
Volume: 7
Parent Publication: Royal Society open science
Issue: 11
ISSN: 2054-5703